Research output per year
Research output per year
Personal profile
Headline
Associate Professor
Fingerprint
Dive into the research topics where Triparna Sen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Erratum: Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer (Cell Reports Medicine (2024) 5(12), (S2666379124006232), (10.1016/j.xcrm.2024.101852))
Chakraborty, S., Sen, U., Ventura, K., Jethalia, V., Coleman, C., Sridhar, S., Banerjee, A., Ozakinci, H., Mahendravarman, Y., Snioch, K., de Stanchina, E., Shields, M. D., Tomalin, L. E., Demircioglu, D., Boyle, T. A., Tocheva, A., Hasson, D. & Sen, T., 18 Feb 2025, In: Cell Reports Medicine. 6, 2, 101944.Research output: Contribution to journal › Comment/debate
Open Access -
Protocol to co-culture SCLC cells with human CD8+ T cells to measure tumor cell killing and T cell activation
Chakraborty, S., Sridhar, S., Ventura, K., Sritharan, R., Tocheva, A. & Sen, T., 20 Jun 2025, In: STAR Protocols. 6, 2, 103767.Research output: Contribution to journal › Article › peer-review
Open Access -
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
Sen, T., Dotsu, Y., Corbett, V., Puri, S., Sen, U., Boyle, T. A., Mack, P., Hirsch, F., Aljumaily, R., Naqash, A. R., Sukrithan, V. & Karim, N. A., Jan 2025, In: The Lancet Oncology. 26, 1, p. e13-e33Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs
Karim, N. A., Rabea, A. M., Mack, P. C., Subramanian, J., Khalil, E., Sherif, M., Marawan, R., Gaafar, T., Shash, L., Suzuki, K., Ahluwalia, M., Wahba, H., Aboelela, S., Al Ahmadi, A., Al Husaini, H., Mohsen, N., Khaled, R., Kassem, N., Khaled, H. & El Said, N. & 12 others, , Jan 2025, In: JTO Clinical and Research Reports. 6, 1, 100776.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
Taniguchi, H., Chakraborty, S., Takahashi, N., Banerjee, A., Caeser, R., Zhan, Y. A., Tischfield, S. E., Chow, A., Nguyen, E. M., Villalonga, Á. Q., Manoj, P., Shah, N. S., Rosario, S., Hayatt, O., Qu, R., Stanchina, E. D., Chan, J., Mukae, H., Thomas, A. & Rudin, C. M. & 1 others, , 27 Sep 2024, In: Science advances. 10, 39, eado4618.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Describe New Findings in Lung Cancer (Lurbinectedin Sensitizes Pd-l1 Blockade Therapy By Activating Sting-ifn Signaling In Small-cell Lung Cancer)
Tocheva, A., Sen, T. & Sen, U.
12/03/25
1 item of Media coverage
Press/Media
-
-
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer
20/12/24
2 items of Media coverage
Press/Media
-
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer
19/12/24
1 item of Media coverage
Press/Media
-
Mount Sinai Study Reveals Immune-Modulatory Mechanism of Lurbinectedin in Small-Cell Lung Cancer
18/12/24
1 item of Media coverage
Press/Media